GCP
GSA Capital Partners’s AstraZeneca AZN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.63M | Buy |
+51,984
| New | +$3.63M | 0.25% | 30 |
|
|
2025
Q1 | – | Sell |
-3,952
| Closed | -$259K | – | 1646 |
|
|
2024
Q4 | $259K | Buy |
+3,952
| New | +$259K | 0.02% | 1286 |
|
|
2024
Q3 | – | Sell |
-4,871
| Closed | -$380K | – | 1591 |
|
|
2024
Q2 | $380K | Buy |
+4,871
| New | +$380K | 0.03% | 1138 |
|
|
2022
Q2 | – | Sell |
-4,428
| Closed | -$294K | – | 1400 |
|
|
2022
Q1 | $294K | Buy |
+4,428
| New | +$294K | 0.04% | 905 |
|
|
2019
Q4 | – | Sell |
-8,449
| Closed | -$377K | – | 1424 |
|
|
2019
Q3 | $377K | Buy |
+8,449
| New | +$377K | 0.05% | 731 |
|
|
2016
Q2 | – | Sell |
-16,070
| Closed | -$453K | – | 1733 |
|
|
2016
Q1 | $453K | Buy |
+16,070
| New | +$453K | 0.03% | 1081 |
|
|
2014
Q2 | – | Sell |
-5,343
| Closed | -$347K | – | 1799 |
|
|
2014
Q1 | $347K | Buy |
+5,343
| New | +$347K | 0.02% | 1022 |
|
|
2013
Q3 | – | Sell |
-4,964
| Closed | -$235K | – | 1553 |
|
|
2013
Q2 | $235K | Buy |
+4,964
| New | +$235K | 0.03% | 1004 |
|